Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

(2021) Brian J. Boyarsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients

(2021) Ilies Benotmane et al.   KIDNEY INTERNATIONAL

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

T cell and antibody responses to SARS‐CoV‐2: experience from a French transplantation and hemodialysis center during the COVID‐19 pandemic

(2020) Sophie Candon et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.

(2020) Kitty J. Jager et al.   KIDNEY INTERNATIONAL

An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants.

(2020) Sophie Caillard et al.   KIDNEY INTERNATIONAL

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of COVID‐19 in solid organ transplant recipients

(2020) Lara Danziger‐Isakov et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Is Covid‐19 infection more severe in kidney transplant recipients?

(2020) Sophie Caillard et al.   AMERICAN JOURNAL OF TRANSPLANTATION

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

(2020) Olivier Thaunat et al.   KIDNEY INTERNATIONAL

Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation

(2019) Karen M. Krueger et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Opportunistic infections after conversion to belatacept in kidney transplantation

(2019) Dominique Bertrand et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Influenza vaccine strategies for solid organ transplant recipients

(2018) Cédric Hirzel et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies

(2017) Nicolle H. R. Litjens et al.   Frontiers in Immunology

Changes of immunogenic profiles between a single dose and one booster influenza vaccination in hemodialysis patients – an 18-week, open-label trial

(2016) Yu-Tzu Chang et al.   Scientific Reports

Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

(2015) P. Pérez-Romero et al.   CLINICAL MICROBIOLOGY AND INFECTION

Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients

(2014) Marc Lúcia et al.   CLINICAL INFECTIOUS DISEASES

Vaccination in Solid Organ Transplantation

(2013) L. Danziger-Isakov et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review

(2013) Isabella Eckerle et al.   PLoS One

Efficacy of Influenza A H1N1/2009 Vaccine in Hemodialysis and Kidney Transplant Patients

(2011) M. Crespo et al.   Clinical Journal of the American Society of Nephrology

Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients

(2011) Paungpaga Lertdumrongluk et al.   VACCINE

Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses

(2010) Geertrude H. Struijk et al.   KIDNEY INTERNATIONAL